In contrast to tumor cells, studies by Chikamatsu et al. report that CD44+TISCs demonstrated expression levels of the molecules involved in antigen presentation machinery (APM), such as LMP2, LMP7, TAP1 etc., equivalent to that of CD44 negative stromal non-stem cells. The gene discussed is CD44; the disease is neoplasm.